Saved in:
| Main Author: | Mamoor, Shahan |
|---|---|
| Format: | Recurso digital |
| Language: | |
| Published: |
Zenodo
2026
|
| Online Access: | https://doi.org/10.5281/zenodo.18980949 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
ATM defects result in Xist modulation.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Telomerase control of Xist through Trf2.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Xist is activated during resistance in triple negative breast cancer in vitro.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
The range of Xist transcriptional targets in non-small cell lung cancer: MYC.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
The range of Xist transcriptional targets in non-small cell lung cancer: BTBD7.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
The genes encoded at the Dxz locus, DANT2/3, are components of an Xist gene expression regulation apparatus that utilizes quantitative control of message quantity of specific genes to measure and maintain transcription, globally, within homeostatic range.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
BCL2L1 induction in metastasis to the brain in humans with breast cancer.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
SSX2IP induction in basal subtype breast cancer.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Feedback activation of VEGF-A resulting from PAX8 inhibition in cancer cells.
by: Mamoor, Shahan
Published: (2026)
by: Mamoor, Shahan
Published: (2026)
SLX1B is active during transformation and controls relapse and resistance in human cancer.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: PPP1R12B.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Phosphatase targeting in basal-like breast cancer: PPP5C.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Kinase targeting in basal-like breast cancer: STK32C.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in breast cancer for the treatment of liver metastasis: C8orf44.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
ALOX15B activation in ulcerative colitis.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Immunoglobulin-based therapeutic targeting for treatment of metastasis to the skeletal system: C3orf52.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Phosphatase targeting in Luminal B breast cancer: PGP.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Phosphatase targeting in Luminal B breast cancer: PNKP.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Kinase targeting in Luminal B breast cancer: DTYMK.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Kinase targeting in Luminal B breast cancer: CDK5.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MYO9B.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Immunoglobulin-based therapeutic targeting for treatment of metastasis to the skeletal system: ABHD17B.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: BCL11B.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Immunoglobulin-based therapeutic targeting in breast cancer for the treatment of liver metastasis: ACSM2B.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: FAM129B.
by: Mamoor, Shahan
Published: (2026)
by: Mamoor, Shahan
Published: (2026)
Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: SLC1A1.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Unbiased discovery of genes required for pluripotency: Terf1.
by: Mamoor, Shahan
Published: (2026)
by: Mamoor, Shahan
Published: (2026)
A comprehensive description of the circulating tumor cell: HCAR1.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Matrix metalloproteinases MMP1/MMP9 function in melanoma resistance.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: BUB1.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in breast cancer for the treatment of lung metastasis: ENOPH1.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in breast cancer for the treatment of lung metastasis: MTFP1.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in breast cancer for the treatment of liver metastasis: MINPP1.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in breast cancer for the treatment of lung metastasis: PANK1.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in breast cancer for the treatment of lung metastasis: FJX1.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
An expression screen to identify genes important for trastuzumab resistance: Pax8-as1.
by: Mamoor, Shahan
Published: (2026)
by: Mamoor, Shahan
Published: (2026)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MTF1.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: MAT1A.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: NFATC1.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
A comprehensive description of the circulating tumor cell: TM6SF1.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Similar Items
-
ATM defects result in Xist modulation.
by: Mamoor, Shahan
Published: (2025) -
Telomerase control of Xist through Trf2.
by: Mamoor, Shahan
Published: (2025) -
Xist is activated during resistance in triple negative breast cancer in vitro.
by: Mamoor, Shahan
Published: (2025) -
The range of Xist transcriptional targets in non-small cell lung cancer: MYC.
by: Mamoor, Shahan
Published: (2025) -
The range of Xist transcriptional targets in non-small cell lung cancer: BTBD7.
by: Mamoor, Shahan
Published: (2025)